Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses
Research and development	$ 25,266	$ 12,449
General and administrative	5,104	5,325
Total operating expenses	30,370	17,774
Loss from operations	(30,370)	(17,774)
Other income (expense)
Interest income	2,471	4,005
Interest expense	(1,023)	(1,000)
Change in fair value of embedded derivatives	190	(50)
Other expense, net	(64)	(54)
Total other income	1,574	2,901
Net loss	(28,796)	(14,873)
Other comprehensive gain (loss)
Unrealized gain (loss) on marketable securities	63	(456)
Comprehensive loss	$ (28,733)	$ (15,329)
Net loss per common share, basic (in dollars per share)	$ (0.48)	$ (0.25)
Net loss per common share, diluted (in dollars per share)	$ (0.48)	$ (0.25)
Weighted-average shares outstanding, basic (in shares)	60,525,628	59,812,000
Weighted-average shares outstanding diluted (in shares)	60,525,628	59,812,000